|
EP1064022A4
(en)
|
1998-03-13 |
2004-09-29 |
Epimmune Inc |
HLA BINDING PROTEINS AND THEIR USE
|
|
ATE395930T1
(de)
|
1999-10-22 |
2008-06-15 |
Aventis Pasteur |
Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
|
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
|
US9051391B2
(en)
|
2007-06-11 |
2015-06-09 |
Takara Bio Inc. |
Method for expression of specific gene
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
PT2413956T
(pt)
|
2009-04-02 |
2016-12-30 |
Vaxon Biotech |
Identificação, optimização e utilização de epitopos crípticos hla-a24 para imunoterapia
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
ES2635335T3
(es)
|
2010-09-20 |
2017-10-03 |
Biontech Cell & Gene Therapies Gmbh |
Receptores de células T específicos de antígeno y epítopos de células T
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2014207708A2
(en)
|
2013-06-28 |
2014-12-31 |
Auckland Uniservices Limited |
Amino acid and peptide conjugates and conjugation process
|
|
KR101503341B1
(ko)
|
2014-03-12 |
2015-03-18 |
국립암센터 |
자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
|
|
AU2014407539B2
(en)
|
2014-10-02 |
2020-10-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation
|
|
AU2015343013B2
(en)
|
2014-11-05 |
2020-07-16 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
CN106632658B
(zh)
*
|
2015-11-04 |
2020-10-27 |
广东香雪精准医疗技术有限公司 |
识别ny-eso-1抗原短肽的tcr
|
|
WO2017120428A2
(en)
|
2016-01-06 |
2017-07-13 |
Health Research, Inc. |
Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
|
|
US11396536B2
(en)
|
2016-04-27 |
2022-07-26 |
University Health Network |
Peptide-HLA complexes and methods of producing same
|
|
EP3538113A4
(en)
*
|
2016-11-14 |
2020-08-19 |
Fred Hutchinson Cancer Research Center |
HIGH AFFINITY MERKEL CELL POLYOMAVIRUS T ANTIGEN SPECIFIC TCRs AND THEIR USES
|
|
CA3111381A1
(en)
*
|
2018-09-05 |
2020-04-30 |
The Regents Of The University Of California |
Composition of ny-eso-1-specific t cell receptors restricted on multiple major histocompatibility complex molecules
|
|
CN113795585B
(zh)
|
2019-03-04 |
2026-03-06 |
大学健康网络 |
T细胞受体及其使用方法
|
|
MX2021010541A
(es)
|
2019-03-04 |
2021-12-15 |
Univ Health Network |
Receptores de linfocitos t y metodos de uso de estos.
|
|
JP7748284B2
(ja)
|
2019-03-04 |
2025-10-02 |
ユニバーシティー ヘルス ネットワーク |
Ｔ細胞受容体及びその使用方法
|
|
EP3935171A4
(en)
|
2019-03-04 |
2022-12-28 |
University Health Network |
T-CELL RECEPTORS AND METHODS OF USE THEREOF
|
|
WO2020178738A1
(en)
|
2019-03-04 |
2020-09-10 |
University Health Network |
T cell receptors and methods of use thereof
|
|
AU2020231927A1
(en)
|
2019-03-04 |
2021-09-30 |
University Health Network |
T cell receptors and methods of use thereof
|
|
CN113795586B
(zh)
|
2019-03-25 |
2026-03-27 |
大学健康网络 |
T细胞受体及其使用方法
|
|
MX2022001210A
(es)
|
2019-07-30 |
2022-05-03 |
Univ Health Network |
Moléculas de complejo mayor de histocompatibilidad (mhc) de clase ii y métodos para su uso.
|
|
CA3146303A1
(en)
|
2019-07-30 |
2021-02-04 |
Naoto Hirano |
T cell receptors and methods of use thereof
|
|
JP7669346B2
(ja)
|
2019-07-30 |
2025-04-28 |
ユニバーシティー ヘルス ネットワーク |
Ｔ細胞受容体及びその使用方法
|
|
JP7724203B2
(ja)
|
2019-07-30 |
2025-08-15 |
ユニバーシティー ヘルス ネットワーク |
Ｔ細胞受容体を識別する方法
|
|
KR20220040489A
(ko)
|
2019-07-30 |
2022-03-30 |
유니버시티 헬스 네트워크 |
T 세포 수용체 및 이의 사용 방법
|
|
KR20220052944A
(ko)
|
2019-07-30 |
2022-04-28 |
유니버시티 헬스 네트워크 |
Mhc 클래스 ii 분자 및 이의 사용 방법
|
|
US20220281948A1
(en)
|
2019-07-30 |
2022-09-08 |
University Health Network |
Mhc class ii molecules and methods of use thereof
|
|
EP4423116A4
(en)
*
|
2021-10-25 |
2025-12-17 |
Univ California |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOM
|